Serum autotaxin level: a promising diagnostic biomarker in differentiating Graves’ disease and thyroiditis
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgae073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Angel George und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha, Ernakulam, Kerala 686661, India. Hauptthemen laut MEDLINE: Graves Disease, Biomarkers, Phosphoric Diester Hydrolases, Thyroiditis. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Recent studies have suggested that serum autotaxin (ATX) may be a promising diagnostic biomarker in differentiating between Graves’ disease (GD) and thyroiditis, as well as serving as a monitoring biomarker for GD. This study will evaluate the use of serum ATX as a diagnostic biomarker in these conditions.
Methods
In this prospective interventional study, blood samples were collected from the patients who met both inclusion and exclusion criteria, and serum ATX levels were measured by using the MyBioSource human Autotaxin ELISA kit.
Results
A total of 32 patients were enrolled, of which 18.8% were newly diagnosed with GD, 21.9% were thyroiditis, and 59.3% were on treatment for GD. Serum autotaxin antigen was significantly higher in GD patients than in thyroiditis (603.3217 ± 444.24 v/s 214.74 ± 55.91, P = <.005). Serum ATX measurement successfully discriminated GD patients from thyroiditis (AUC = 0.952, 95%CI: 0.00–1.00) with an optimal cutoff value of ≥257.20 ng/L (sensitivity = 100 and specificity = 81.71). Monitoring the efficacy of serum ATX was analyzed and showed a significant difference.
Conclusion
The serum ATX was higher in subjects with GD as compared to thyroiditis, and ATX levels were found to be decreased during the treatment period. In conclusion, serum ATX can be used as a diagnostic and monitoring biomarker in GD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha, Ernakulam, Kerala 686661, India.
- Department of Pharmacology, Grace College of Pharmacy, Palakkad, Kerala 678004, India.
- Department of Endocrinology, Caritas Hosptial, Thellakom, Kottayam 686630, India.
ORCID-Profile: Angel George, Anns Mariya, Manu Eappen, Marimuthu Karthikeyan
Zitieren
APA
George, A., Mariya, A., Eappen, M., Karthikeyan, M., & Sreenath, R. (2025). Serum autotaxin level: a promising diagnostic biomarker in differentiating Graves’ disease and thyroiditis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae073
Vancouver
George A, Mariya A, Eappen M, Karthikeyan M, Sreenath R. Serum autotaxin level: a promising diagnostic biomarker in differentiating Graves’ disease and thyroiditis. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae073
BibTeX
@article{George2025,
author = {George, Angel and Mariya, Anns and Eappen, Manu and Karthikeyan, Marimuthu and Sreenath, Ravindranath},
title = {Serum autotaxin level: a promising diagnostic biomarker in differentiating Graves’ disease and thyroiditis},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgae073}
}
EUVIMED